Published in Int J Androl on June 01, 1999
NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest. J Biol Chem (2000) 1.64
Evolutionary variation of the CCAAT-binding transcription factor NF-Y. Nucleic Acids Res (1992) 1.60
The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated. Oncogene (1999) 1.47
A molecular study of a family with Greek hereditary persistence of fetal hemoglobin and beta-thalassemia. EMBO J (1984) 1.44
Regulation of the CCAAT-Binding NF-Y subunits in Arabidopsis thaliana. Gene (2001) 1.42
Down-regulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with loss of functional CCAAT-binding NF-Y complex. Oncogene (1999) 1.35
Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743. Proc Natl Acad Sci U S A (2000) 1.34
Intron-exon organization of the NF-Y genes. Tissue-specific splicing modifies an activation domain. J Biol Chem (1992) 1.32
Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements. Nucleic Acids Res (1989) 1.28
CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues. Nucleic Acids Res (1997) 1.24
The E alpha promoter: a linker-scanning analysis. J Immunol (1991) 1.21
NF-Y associates with H3-H4 tetramers and octamers by multiple mechanisms. Mol Cell Biol (1999) 1.15
Synergistic activation of transcription by nuclear factor Y and sterol regulatory element binding protein. J Lipid Res (1998) 1.12
Sardinian G gamma-HPFH: a T----C substitution in a conserved "octamer" sequence in the G gamma-globin promoter. Blood (1988) 1.12
Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. Int J Obes Relat Metab Disord (1999) 1.11
CCAAT-box binding protein NF-Y (CBF, CP1) recognizes the minor groove and distorts DNA. Nucleic Acids Res (1995) 1.11
The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ. Oncogene (2008) 1.10
A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y. Mol Cell Biol (2000) 1.06
NF-Y binding to twin CCAAT boxes: role of Q-rich domains and histone fold helices. J Mol Biol (1999) 1.05
miR-205 regulates basement membrane deposition in human prostate: implications for cancer development. Cell Death Differ (2012) 1.05
Cloning and expression of human NF-YC. Gene (1997) 1.02
Indirect genetic effects and the genetic bases of social dominance: evidence from cattle. Heredity (Edinb) (2012) 1.01
Increased erythroid-specific expression of a mutated HPFH gamma-globin promoter requires the erythroid factor NFE-1. Nucleic Acids Res (1989) 1.01
Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y? Cell Death Differ (2013) 1.01
Mitochondrial membrane potential and DNA stainability in human sperm cells: a flow cytometry analysis with implications for male infertility. Exp Cell Res (1998) 1.00
Dissection of the NF-Y transcriptional activation potential. Nucleic Acids Res (1999) 0.99
NF-Y histone fold alpha1 helices help impart CCAAT specificity. J Mol Biol (1999) 0.99
Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha-2-adrenergic receptors in the rostral ventrolateral medulla. J Hypertens Suppl (1988) 0.99
Role of oestrogen in male sexual behaviour: insights from the natural model of aromatase deficiency. Clin Endocrinol (Oxf) (1999) 0.98
A role of insular cortex in cardiovascular function. J Comp Neurol (1987) 0.98
NF-Y organizes the gamma-globin CCAAT boxes region. J Biol Chem (1998) 0.98
Cooperation and competition between the binding of COUP-TFII and NF-Y on human epsilon- and gamma-globin gene promoters. J Biol Chem (2001) 0.97
Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. J Clin Endocrinol Metab (2000) 0.97
Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter. J Mol Biol (2000) 0.97
Ca2+-dependence of 3H-catecholamines release evoked by black widow spider venom gland extract in rat hypothalamus, occipital cortex and caudate nucleus. Acta Physiol Lat Am (1983) 0.96
Neurons of C1 area mediate cardiovascular responses initiated from ventral medullary surface. Am J Physiol (1986) 0.95
Brain stem area with C1 epinephrine neurons mediates baroreflex vasodepressor responses. Am J Physiol (1985) 0.95
Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH. Eur J Endocrinol (2001) 0.94
Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription. Nucleic Acids Res (1995) 0.94
Glutamatergic mechanisms in the nucleus tractus solitarius in blood pressure control. Fed Proc (1984) 0.94
Effect of ecteinascidin-743 on the interaction between DNA binding proteins and DNA. Anticancer Drug Des (1999) 0.94
An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla. Life Sci (1986) 0.93
HSP-CBF is an NF-Y-dependent coactivator of the heat shock promoters CCAAT boxes. J Biol Chem (2001) 0.93
Inhibition of ERalpha-mediated trans-activation of human coagulation factor XII gene by heteromeric transcription factor NF-Y. Endocrinology (2001) 0.93
NF-Y is essential for expression of the proapoptotic bim gene in sympathetic neurons. Cell Death Differ (2010) 0.93
Adrenal responsiveness to high, low and very low ACTH 1-24 doses in obesity. Clin Endocrinol (Oxf) (2000) 0.92
Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. Metabolism (1992) 0.91
Effects of cocaine or denervation on responses of isolated strips of cat spleen to (-)-noradrenaline and (-)-isoprenaline. Br J Pharmacol (1973) 0.91
The 3' ends of the deletions of Spanish delta beta zero-thalassemia and black HPFH 1 and 2 lie within 17 kilobases. Blood (1987) 0.90
p63 regulates the caspase-8-FLIP apoptotic pathway in epidermis. Cell Death Differ (2008) 0.90
Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults. Neuroendocrinology (1991) 0.90
Role of adrenaline neurons of ventrolateral medulla (the C1 group) in the tonic and phasic control of arterial pressure. Clin Exp Hypertens A (1984) 0.90
Interactions of the CCAAT-binding trimer NF-Y with nucleosomes. J Biol Chem (1999) 0.90
A ligand-receptor pair that triggers a non-apoptotic form of programmed cell death. Cell Death Differ (2002) 0.89
Material properties assignment to finite element models of bone structures: a new method. Med Eng Phys (1998) 0.89
A new p63-deficient mouse model or a fresh look at an old one? Cell Death Differ (2009) 0.89
Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. J Clin Endocrinol Metab (2003) 0.88
Conservation and divergence of NF-Y transcriptional activation function. Nucleic Acids Res (1998) 0.88
Evidence that glutamic acid is the neurotransmitter of baroreceptor afferent terminating in the nucleus tractus solitarius (NTS). J Auton Nerv Syst (1981) 0.88
Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol (Oxf) (2004) 0.88
The major histocompatibility complex class II Ea promoter requires TFIID binding to an initiator sequence. Mol Cell Biol (1996) 0.88
Mutant p53 subverts p63 control over KLF4 expression in keratinocytes. Oncogene (2010) 0.87
Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome. J Clin Endocrinol Metab (2002) 0.87
The same nuclear proteins bind the proximal CACCC box of the human beta-globin promoter and a similar sequence in the enhancer. Biochem Biophys Res Commun (1989) 0.87
A1 noradrenergic neurons tonically inhibit sympathoexcitatory neurons of C1 area in rat brainstem. Brain Res (1986) 0.87
DNA sequences regulating human globin gene transcription in nondeletional hereditary persistence of fetal hemoglobin. Hemoglobin (1989) 0.86
Lesions of epinephrine neurons in the rostral ventrolateral medulla abolish the vasodepressor components of baroreflex and cardiopulmonary reflex. Hypertension (1984) 0.86
Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism. Diabet Med (2009) 0.85
Leydig cell tumor in an anabolic steroid abuser. J Endocrinol Invest (2013) 0.85
Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects. Int J Obes Relat Metab Disord (1997) 0.84
Thyroid volume and urinary iodine excretion in the schoolchild population of a Northwestern Italian sub-Alp metropolitan area. J Endocrinol Invest (2004) 0.84
The p63 target HBP1 is required for skin differentiation and stratification. Cell Death Differ (2010) 0.84
Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients. G Ital Cardiol (1998) 0.84
Neuroactive drugs in growth disorders. Acta Paediatr Scand Suppl (1990) 0.83
Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1. Oncogene (2000) 0.83
Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. Int J Obes Relat Metab Disord (2001) 0.83
Cardiac effects of hexarelin in hypopituitary adults. Eur J Pharmacol (1999) 0.83
Cloning and characterization of the histone-fold proteins YBL1 and YCL1. Nucleic Acids Res (2000) 0.83
NF-Y joins E2Fs, p53 and other stress transcription factors at the apoptosis table. Cell Death Dis (2011) 0.83
Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity. J Endocrinol Invest (1999) 0.83
Mutations in the A gamma-globin promoter in hereditary persistence of fetal hemoglobin and delta beta zero-thalassemia. Prog Clin Biol Res (1987) 0.83
Influence of vitrification techniques and solutions on the morphology and survival of preantral follicles after in vitro culture of caprine ovarian tissue. Theriogenology (2011) 0.82
Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity. Eur J Endocrinol (1996) 0.82
Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test. J Endocrinol Invest (1999) 0.82
Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents. Int J Cancer (2011) 0.82
Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women. Clin Endocrinol (Oxf) (1999) 0.82
Congenital estrogen deficiency: in search of the estrogen role in human male reproduction. Mol Cell Endocrinol (2001) 0.81
The effects of transdermal estradiol on the response to mental stress in postmenopausal women: a randomized trial. Am J Med (2000) 0.81
Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patients. Vaccine (1990) 0.81
Change in body condition score of Holstein cows as affected by parity and mature equivalent milk yield. J Dairy Sci (1996) 0.81
Brain stem catecholamine mechanisms in tonic and reflex control of blood pressure. Hypertension (1984) 0.81
In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion. J Clin Endocrinol Metab (1997) 0.81
In vivo release by vagal stimulation of L-[3H] glutamic acid in the nucleus tractus solitarius preloaded with L-[3H] glutamine. Brain Res Bull (1984) 0.81